China cuts back on high-tech diagnostic reimbursement
This article was originally published in Clinica
The Chinese government is to impose restrictions on the reimbursement of examinations using large-scale, high-tech diagnostic equipment. The move, which applies to patients covered by the country's free healthcare service rather than the new health insurance systems springing up throughout China, is an attempt to control the rapid rise in spending on diagnostic procedures using sophisticated equipment.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.